David’s in remission after compassionate drug access
David’s AL amyloidosis is in remission following compassionate access to daratumumab.
- Amyloidosis
Category: Stories
New international trial for amyloidosis
In a first-ever Australian-French collaboration, an exciting new clinical trial, due to open before Christmas, will give Australians with relapsed or refractory AL amyloidosis access to a new drug combination.
- Amyloidosis
- Clinical trials
- Research
- Treatments and side-effects
Helen’s steps to a gift in Will
Helen has no idea how many kilometres she walked with her beloved pooch Prinnie for over 15 years collecting for the Leukaemia Foundation Doorknock campaign. But she does know every step was worth it to help save the lives of children with blood cancer – like her young friend, Rachel, who was diagnosed with leukaemia in 1991.
- Acute lymphoblastic leukaemia
- Our supporters
Will’s first Father’s Day after beating blood cancer
After beating blood cancer and becoming a first-time dad, Will decided to take care of his mental health.
- Acute lymphoblastic leukaemia
The scary reality: blood cancer can affect anyone at any time
When Hayley Bugno was diagnosed with blood cancer only a year after having her third baby, she was confronted with the ‘scary reality’ that the disease does not discriminate and can strike when least expected.
- Acute myeloid leukaemia
Rare blood cancer claims the life of ‘Island Child’ Benji
Living a peaceful and idyllic life on tropical Christmas Island, the Kentwell family could never have anticipated the pain blood cancer could bring to their lives.
- Other blood cancers
Venetoclax received PBAC recommendation for AML
The 'miracle drug' was among eight blood cancer treatments recommended by the PBAC at its July 2021 meeting.
- Acute myeloid leukaemia
Expert Series: Dr Ilaria Pagani talks treatment-free remission in CML
Dr Pagani has a vision for a personalised approach to treatment-free remission in CML
- Chronic myeloid leukaemia
- Interviews with experts
- Research
Heather’s in treatment-free remission
Heather Jenkins was one of the first Australians to go on a clinical trial for the first targeted therapy for chronic myeloid leukaemia (CML).
- Chronic myeloid leukaemia
Revised AML, DLBCL and HL Optimal Care Pathways released
Newly revised optimal care pathways (OCPs) provide best practice information for the treatment and care of people living with acute myeloid leukaemia (AML), and diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL).
- Acute myeloid leukaemia
- Chronic myeloid leukaemia
- Hodgkin lymphoma
- “Live life to the fullest”: Josh Gourlay opens up about returning to work and new beginnings after blood cancer
- Advocacy news – July 2024
- Talking Blood Cancer: Estate planning and medical directives
- Running for a Cause: Cal Gates’ Journey from Newcastle to Sydney on foot in one weekend
- World Blood Cancer Day 2024